Rare diseases
Investigational molecules
Locations
Clinical trials in Bulgaria – page 4834 clinical trials in Bulgaria across 40 research sites in 53 cities. Every trial is listed in the EU Clinical Trials Register and updated daily.
BulgariaBulgariaBulgariaBulgariaBulgariaBulgariaBulgariaBulgariaBulgariaBulgariaBulgariaBulgariaWhere most of the country's trials are run
Shares are of these cities' trials together.
53 cities, A–Z – pick yours to filter the trials
What the registry says about research in the country
Clinical research in Bulgaria encompasses a wide range of oncological conditions, with significant focus on both solid tumors and hematological malignancies. Studies investigate novel therapies for non-small cell lung cancer, including those with specific genetic mutations such as EGFR and HER2, as well as small cell lung cancer. Research also addresses breast cancer across various stages and molecular subtypes, particularly hormone receptor-positive and HER2-negative variants.
Trials evaluate targeted therapies, immunotherapies, and combination treatment approaches aimed at improving survival outcomes and quality of life for patients with various malignancies.
A substantial portion of clinical trials in the country focuses on autoimmune disorders and chronic inflammatory conditions. Research addresses diseases affecting multiple organ systems, with particular emphasis on rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Studies investigate both biologic and small molecule therapies designed to modulate immune responses and reduce disease activity.
These trials assess the efficacy of novel immunomodulatory agents in achieving disease remission, controlling symptoms, and preventing long-term complications associated with chronic inflammation.
Bulgarian clinical research sites participate extensively in studies examining cardiovascular diseases and metabolic disorders. Investigations focus on conditions such as heart failure with various ejection fraction phenotypes, atrial fibrillation, and atherosclerotic cardiovascular disease. Research also addresses prevention of major adverse cardiovascular events following acute myocardial infarction and stroke.
Trials evaluate therapeutic interventions aimed at reducing cardiovascular risk, improving metabolic parameters, and preventing disease progression in high-risk populations.
Clinical trials addressing respiratory conditions represent an important research area. Studies investigate treatments for chronic obstructive pulmonary disease across various severity levels, with focus on reducing exacerbations and improving lung function. Research also encompasses asthma, particularly severe and eosinophilic phenotypes requiring advanced therapeutic approaches.
Research efforts aim to develop more effective treatments for both acute respiratory conditions and chronic progressive lung diseases, with emphasis on improving patient outcomes and quality of life.
Neurological research in Bulgaria encompasses diverse conditions affecting the central and peripheral nervous systems. Significant attention is directed toward multiple sclerosis, including relapsing-remitting and progressive forms, with trials evaluating disease-modifying therapies. Studies also address epilepsy, particularly focal-onset and primary generalized seizures requiring novel anticonvulsant approaches.
These trials investigate therapies aimed at slowing disease progression, managing symptoms, and improving neurological function in patients with various disorders of the nervous system.
Clinical research addresses various psychiatric conditions and behavioral disorders. Studies focus on major depressive disorder, including treatment-resistant forms and those with specific symptom profiles such as anhedonia. Research also examines schizophrenia and bipolar disorder, evaluating both acute symptom management and long-term disease control.
Trials assess novel pharmacological interventions designed to improve psychiatric symptoms, cognitive function, and overall mental health outcomes in affected populations.
Research in liver diseases and gastrointestinal disorders addresses both acute and chronic conditions. Studies investigate chronic hepatitis B and D infections, exploring antiviral therapies and immune-modulating approaches. Significant research focuses on metabolic dysfunction-associated steatohepatitis and non-alcoholic fatty liver disease, conditions with increasing prevalence worldwide.
Clinical trials evaluate therapeutic strategies aimed at reducing liver inflammation, preventing fibrosis progression, and managing complications of advanced liver disease.
Research in hematological conditions extends beyond malignancies to include benign blood disorders. Studies address hemophilia A and B, investigating both replacement therapies and novel approaches for patients with and without inhibitors. Research also focuses on immune thrombocytopenia and other platelet disorders affecting bleeding and clotting mechanisms.
Trials evaluate therapies designed to normalize blood cell counts, prevent bleeding complications, and reduce thrombotic risk in various hematological conditions.
Dermatological research addresses a spectrum of skin conditions ranging from inflammatory to autoimmune disorders. Studies investigate atopic dermatitis across different age groups, evaluating systemic therapies for moderate to severe disease. Research also encompasses psoriasis and psoriatic arthritis, examining both cutaneous and joint manifestations.
Clinical trials assess novel therapeutic approaches aimed at controlling skin inflammation, reducing disease activity, and improving quality of life for patients with chronic dermatological conditions.
Clinical research in eye diseases focuses on conditions affecting vision and ocular health. Studies investigate treatments for neovascular age-related macular degeneration and diabetic macular edema, evaluating intravitreal therapies designed to preserve or improve visual acuity. Research also addresses retinal vein occlusion and associated macular complications.
Trials evaluate therapeutic interventions aimed at preventing vision loss, reducing intraocular inflammation, and managing complications of various ocular diseases.
Research in infectious diseases addresses both acute and chronic infections. Studies investigate treatments for bacterial infections including complicated urinary tract infections, skin and soft tissue infections, and hospital-acquired pneumonia. Research also focuses on viral infections, particularly chronic hepatitis and emerging respiratory pathogens.
Clinical trials evaluate antimicrobial agents, antiviral therapies, and immunomodulatory approaches designed to improve outcomes in patients with serious infections.
Clinical research addresses various kidney diseases and their complications. Studies focus on chronic kidney disease across different stages, investigating therapies to slow progression and reduce associated cardiovascular risk. Research also examines IgA nephropathy and other glomerular diseases, evaluating treatments aimed at reducing proteinuria and preserving renal function.
Trials assess therapeutic strategies designed to protect kidney function, manage complications of renal disease, and improve outcomes in patients with progressive kidney disorders.
Research in endocrine conditions encompasses hormonal disorders affecting multiple body systems. Studies investigate Cushing's syndrome and other conditions of hormonal excess, evaluating therapies to normalize hormone levels. Research also addresses acromegaly, congenital adrenal hyperplasia, and thyroid disorders including Graves' disease.
Clinical trials evaluate hormonal therapies, metabolic interventions, and disease-modifying treatments aimed at restoring endocrine balance and preventing long-term complications.
Clinical research addresses various rare diseases and genetic conditions with significant unmet medical needs. Studies investigate treatments for hereditary transthyretin amyloidosis, erythropoietic protoporphyria, and other inherited metabolic disorders. Research also focuses on Duchenne muscular dystrophy and conditions amenable to genetic therapies.
Trials evaluate novel therapeutic approaches including gene therapies, enzyme replacement, and targeted molecular interventions designed to address underlying disease mechanisms in rare genetic disorders.
Research in diagnostic techniques and medical imaging evaluates novel contrast agents and imaging methodologies. Studies assess gadolinium-based contrast agents for magnetic resonance imaging applications, comparing safety profiles and diagnostic efficacy. Research also investigates imaging approaches for assessing disease activity and treatment response across various conditions.
Clinical trials aim to improve diagnostic accuracy, enhance imaging safety, and develop more effective tools for disease monitoring and treatment evaluation.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
